Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging–Targeted Biopsy: Transforming Prostate Cancer Diagnosis

Advances in artificial intelligence (AI) and medical imaging have opened new avenues for the diagnosis and management of prostate cancer. In particular, AI technology can enhance the performance of fusion magnetic resonance imaging–targeted biopsy of the prostate, and has the potential to enhance the usability and precision of this biopsy technique, guide treatment decisions, and further advance prostate cancer care.